HC Deb 04 November 1997 vol 300 cc183-4W
Helen Jackson

To ask the Secretary of State for Health what action he is taking to ensure uniformity of treatment for multiple sclerosis sufferers across the United Kingdom. [13785]

Mr. Boateng

We are keen to ensure a greater degree of equity in the availability of treatment for people with multiple sclerosis, wherever they may live. Existing guidance requires all health authorities to develop policies which allow the prescribing of beta interferon, in relation to alternative uses of available resources, in suitable cases.

Helen Jackson

To ask the Secretary of State for Health how many patients suffering from multiple sclerosis were offered beta interferon by each heath authority in(a) 1995, (b) 1996 and (c) 1997. [13807]

Mr. Milburn

We do not know how many patients were offered beta-interferon, but the number of prescription items for beta-interferon products dispensed in the community in England is shown in the table. In order not to disclose information that may relate to an individual patient, information is only provided where 50 items or more have been dispensed. In no health authority in 1995 were 50 or more items dispensed.

Prescription items for beta-interferon dispensed in the community in England
1995 1996
Berkshire 75
West Surrey 142
East Surrey 81
Ealing Hammersmith and Hounslow 85
England 182 806

Comparable data for 1997 are not yet available.

The cost of prescribing beta interferon in hospitals is not available.